Study Uncovers Potential Treatments for Preventing Cancer and Infectious Diseases

Study Uncovers Potential Treatments for Preventing Cancer and Infectious Diseases

A collaborative study conducted by Federation University Australia and the Murdoch Children’s Research Institute has revealed the origin and function of a specific type of immune cell responsible for defending the body against diseases and infections. This newfound understanding may pave the way for the development of preventative medications to combat cancer and highly contagious diseases such as COVID-19, Strep A, and tuberculosis.

The study, published in Science Immunology, involved the analysis of samples from heart surgery patients up to the age of 16 obtained from the Melbourne Children’s Heart Tissue Bank. Researchers focused on examining “gamma delta T cells” within the context of the thymus gland, a small organ located in the chest near the heart.

According to Associate Professor Dan Pellicci, the study marks the first time that the production of these infection-fighting immune cells in the thymus organ has been demonstrated. He explained, “We have a significant number of these specialized cells in our blood and tissues, which accumulate as we mature into adults. However, until our study, it remained unclear how these cells develop in the body.” He further elaborated, “We have now shown how these cells undergo three stages of training, similar to receiving primary, secondary, and tertiary education, within the thymus. Following this education, the cells are ready to circulate throughout the body and effectively combat infections.”

The study challenges the previous assumption that these immune cells primarily originate in the liver during fetal development. Instead, the research highlights the significant role of the thymus in the ongoing development of these cells as individuals age. Associate Professor Pellicci emphasized, “The thymus, an often overlooked organ, contributes to the body’s preparation for a lifetime of good health.”

Understanding the functioning and development of these specialized white blood cells holds the potential for unlocking new approaches to treating infectious diseases and cancer. Associate Professor Pellicci concluded, “The more knowledge we acquire about these cells, the greater the likelihood of discovering novel strategies to prevent and combat these diseases.”

IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team


Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks